Vor Biopharma Inc.
VOR
$23.84
-$1.26-5.02%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 70.68M | 61.54M | 50.56M | 39.75M | 32.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 148.11M | 374.54M | 372.67M | 368.02M | 367.40M |
| Operating Income | -148.11M | -374.54M | -372.67M | -368.02M | -367.40M |
| Income Before Tax | 627.78M | -883.08M | -695.98M | -2.45B | -1.66B |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 627.78 | -883.08 | -695.98 | -2.45K | -1.66K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 627.78M | -883.08M | -695.98M | -2.45B | -1.66B |
| EBIT | -148.11M | -374.54M | -372.67M | -368.02M | -367.40M |
| EBITDA | -148.02M | -372.45M | -369.78M | -364.29M | -362.82M |
| EPS Basic | -43.00 | -293.09 | -293.19 | -386.84 | -273.27 |
| Normalized Basic EPS | -27.10 | -183.40 | -183.47 | -241.87 | -170.79 |
| EPS Diluted | -43.00 | -293.09 | -293.19 | -386.84 | -273.27 |
| Normalized Diluted EPS | -27.10 | -183.40 | -183.47 | -241.87 | -170.79 |
| Average Basic Shares Outstanding | 124.29M | 76.25M | 39.48M | 22.69M | 19.43M |
| Average Diluted Shares Outstanding | 124.29M | 76.25M | 39.48M | 22.69M | 19.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |